Ullmann Michael H
SEC CIK 1537710 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | EVP, GC | 165.0K | — | — | 5 | 2021-06-09 | 2022-02-15 |
Most active insiders at JNJ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| 2 | Wolk Joseph J | EVP, CFO | — | $21.77M |
| 3 | REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| 4 | Swanson James D. | EVP, CIO | — | $15.11M |
| 5 | Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| 6 | Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| 7 | Forminard Elizabeth | EVP, CLO | — | $4.09M |
| 8 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| 9 | Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| 10 | Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Ullmann Michael H made no open-market trades at JNJ in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Ullmann Michael H | EVP, GC | M - OptEx | $0.00 | +13.2K | 165.0K | +9% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Ullmann Michael H | EVP, GC | F - Tax | $165.89 | -6,209 | 158.8K | -4% | -$1.03M |
| DM | 2022-02-15 20:03 | 2021-06-09 | JNJ | Johnson & Johnson | Ullmann Michael H | EVP, GC | G - Gift | $0.00 | -912 | 150.3K | -0.6% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | Ullmann Michael H | EVP, GC | M - OptEx | $0.00 | +2,407 | 152.7K | +2% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | Ullmann Michael H | EVP, GC | F - Tax | $168.85 | -871 | 151.9K | -0.6% | -$147.1K |
Purchase Sale Sale after option exercise All abbreviations